Enter the first few characters of Company and click 'Go'

Audited Results of Jagsonpal Pharmaceuticals Ltd. Company

(Rs in Cr.)	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Operating Income	236.71	226.10	187.95	158.57	168.25
Manufacturing Expenses	0.29	0.47	0.52	0.64	1.41
Personnel Expenses	56.41	57.68	53.98	50.37	46.61
Selling Expenses	15.46	12.09	11.83	16.29	0
Administrative Expenses	37.21	34.11	21.73	26.49	36.53
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	202.56	200.30	168.87	150.04	157.49
Operating Profit	34.15	25.79	19.08	8.53	10.76
Other Recurring Income	5.73	3.34	4.39	2.53	0
Adjusted PBDIT	39.88	29.13	23.47	11.06	10.76
Financial Expenses	0.41	0.29	1.09	0.51	0.75
Depreciation	1.21	1.53	0.51	1.13	1.02
Other Write offs	0	0	0	0	0
Adjusted PBT	38.27	27.32	21.87	9.41	9
Tax Charges	8.09	7.73	4.81	1.54	1.79
Adjusted PAT	30.18	19.59	17.06	7.87	7.22
Non Recurring Items	-5.01	1.36	0.15	0	0
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	26.72	19.59	17.06	7.87	7.22
Equity Dividend	0	10.48	2.62	1.31	0.79
Preference Dividend	0	0	0	0	0
Retained Earnings	94.54	69.05	62.28	47.69	41.13

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article